Analytical Data
-
基因名
CMTM2
- Application
-
别名
CMTM2; CKLFSF2; CKLF-like MARVEL transmembrane domain-containing protein 2; Chemokine-like factor superfamily member 2
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8TAZ6
-
表达区间
1-248aa
-
氨基酸序列
MAPKAAKGAKPEPAPAPPPPGAKPEEDKKDGKEPSDKPQKAVQDHKEPSDKPQKAVQPKHEVGTRRGCRRYRWELKDSNKEFWLLGHAEIKIRSLGCLIAAMILLSSLTVHPILRLIITMEISFFSFFILLYSFAIHRYIPFILWPISDLFNDLIACAFLVGAVVFAVRSRRSMNLHYLLAVILIGAAGVFAFIDVCLQRNHFRGKKAKKHMLVPPPGKEKGPQQGKGPEPAKPPEPGKPPGPAKGKK
-
分子量
53.9 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CMTM2 (Chemokine-like factor 2) is a member of the chemokine-like factor family, implicated in various biological processes including immune response, cell migration, and cancer progression. Research has increasingly focused on CMTM2 due to its potential role in tumorigenesis and its association with several diseases, including autoimmune disorders and certain cancers. The protein exhibits a unique structure characterized by a key functional domain that facilitates interactions with other cellular proteins, influencing signaling pathways. Additionally, CMTM2 is known to modulate processes such as apoptosis and cell proliferation, highlighting its importance in maintaining cellular homeostasis. Despite its potential relevance, the precise mechanisms of CMTM2 are not thoroughly understood, prompting investigations into its functional properties, expression patterns, and molecular interactions. Recombinant CMTM2 protein production has emerged as a crucial tool for elucidating the protein's biological functions and for exploring its therapeutic potential. Such studies aim to establish CMTM2 as a viable biomarker and therapeutic target, thereby contributing to the development of novel treatment strategies in oncology and immunological diseases. Overall, understanding CMTM2 through recombinant protein research holds promise for advancing knowledge in biomedical science and enhancing therapeutic approaches in a clinical setting.
